Project Grant HT94252410160
- The University of Iowa was awarded a $311,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying the temporal and spatial origins and reversibility of neurodevelopmental disorders with autism in mouse models. The grant, awarded on June 1, 2024, will fund this research project through May 31, 2026. The Military Medical Research and Development program supports biomedical...
- The University of Iowa was awarded a $1,529,022 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research from February 2021 to February 2024 to investigate SUMO inhibition and its ability to repress mammary oncogenesis through the ETV1 protein. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
- This $1,399,501 federal Project Grant awarded by the Defense Health Agency on September 1, 2023 will fund the development of a novel DNA aptamer-based IFN-γ targeted therapy for chronic cystitis pain at the University of Iowa. The project, which is scheduled for completion by August 31, 2027, aligns with the objectives of the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to transform healthcare for Service Members and the American public through...
- The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
- The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
- The Defense Health Agency awarded Brigham & Women's Hospital Inc. a $253,636 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2025 to investigate the role of the secreted factor CTHRC1 in the pathogenesis of tuberous sclerosis complex. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,759,708.00 to Iowa State University of Science and Technology to conduct research on high-throughput, high-resolution in vitro models of prostate cancer bone marrow metastases. The research project runs from April 15, 2025 to April 14, 2028 and aims to develop innovative medical solutions that address critical health challenges relevant to military...
- This federal Project Grant award, totaling $3,560,880, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the public. The primary awardee, the University of Kansas Medical Center Research Institute, Inc. (KUMCRI), will conduct sophisticated scientific investigations to address various medical...
- This Project Grant award in the amount of $816,375.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Iowa. The grant funds a research project titled "MECHANISMS OF NEURONAL DYSREGULATION UNDERLYING BEHAVIORAL ALTERATIONS IN NEUROFIBROMATOSIS TYPE 1" with a performance period from July 1, 2024 to June 30, 2027. This research aims to investigate the neurological mechanisms underlying behavioral...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $748,815 Project Grant to the University of Iowa. The grant, awarded on July 1, 2024, will support the "Women's Health in Tuberous Sclerosis Complex: A Population-Based Assessment of Morbidity to Inform Clinical Care" project. This research aims to provide a comprehensive assessment of the health issues faced by women with tuberous sclerosis complex, a rare genetic disorder, in order to inform improved clinical care. The University of Iowa, a major public research institution, will leverage its expertise and facilities to conduct this population-based study, which is expected to be completed by June 30, 2027. The findings from this research project have the potential to advance the understanding and management of this condition, ultimately benefiting military service members, veterans, and their families.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $748.8k | 3/12/24 |